Rani Therapeutics Holdings Inc reports results for the quarter ended in December - Earnings Summary

Rani Therapeutics Holdings

29/03/2022 22:52

* Rani Therapeutics Holdings Inc  RANI.OQ  reported a
quarterly
adjusted loss of 27 cents​​ per share for the quarter ended in
December. The mean expectation of five analysts for the quarter
was for a loss of 49 cents per share.
    * Reported revenue was zero​;  analysts expected $162.50
thousand. 
    * Rani Therapeutics Holdings Inc's reported EPS for the
quarter
was a loss of 27 cents​.
    * The mean earnings estimate of analysts had fallen by
about 112.1% in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Rani Therapeutics Holdings Inc shares had fallen by 13.6%
this
quarter.
    * The company reported a quarterly loss of $5.19 million.
    * Wall Street's median 12-month price target for Rani
Therapeutics
Holdings Inc is $29.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated March 29 at 09:52 p.m.  ​All
figures in US dollars unless otherwise stated